customs_ledger
TL3 Regular · Rotterdam, NL
Freight forwarding background. I explain customs outcomes without promising them.
Joined 1 August 2024 · last posted 1d · groups: wiki-editors
146 posts, newest first. Showing up to 150.
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #26 · Practice › Side effects · 27 Jul 2026 · 5 likes Where I would push back on the Taste changes and food aversion consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #54 · Clinical › Prescriber conversations · 26 Jul 2026 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. That is where I would start, not where I would stop.
-
Pooling trials with different estimands Replied, post #126 · Evidence › Meta-analyses · 24 Jul 2026 · 17 likes Understood, and I withdraw the assumption I opened with.
-
Tracking intake honestly when appetite is absent Replied, post #112 · Nutrition & Training › Protein & intake · 24 Jul 2026 · 0 likes Coming back to post #108, because the follow-up matters more than the original answer. Tracking intake: I would want to see the raw numbers rather than the summary…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #33 · Clinical › Bloodwork · 24 Jul 2026 · 2 likes That is clearer than the version I had in my head. Thank you.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #74 · Evidence › Journal club · 24 Jul 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #136 · Practice › Reconstitution · 22 Jul 2026 · 11 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
-
Pooling trials with different estimands Replied, post #117 · Evidence › Meta-analyses · 21 Jul 2026 · 28 likes Overlapping populations across included trials inflate the apparent sample size. It happens more than people expect where the same programme reports multiple papers.
-
Why the Start Here categories exist, and what they are not for Replied, post #21 · Start Here › Welcome · 21 Jul 2026 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #48 · Pharmacology › Receptor biology · 18 Jul 2026 · 1 like The C-cell finding in rodent toxicology is a receptor-biology observation with a species-specific interpretation. It is the reason for a specific contraindication…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #85 · Analytics › Impurities & related substances · 17 Jul 2026 · 24 likes Answering the question post #81 raises rather than the one it answers. Truncation products are substantially lower in mass and usually well separated…
-
Retatrutide mass and identity: what a report should show Replied, post #18 · Compounds › Retatrutide · 15 Jul 2026 · 9 likes Post #17 answers the question as asked. The question underneath it is different. Retatrutide is investigational. Material obtained outside a clinical trial is…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #30 · Clinical › Prescriber conversations · 12 Jul 2026 · 0 likes Second this, and I would have said it less carefully.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #67 · Access › Insurance & coverage · 11 Jul 2026 · 8 likes This settles it for me, at least until somebody posts a reason it should not.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #31 · Start Here › Welcome · 11 Jul 2026 · 23 likes A methods point on Reading order rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Substitution between formats during a shortage — what changed since Replied, post #7 · Access › Shortages · 11 Jul 2026 · 0 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated. That is where I would start,…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #17 · Practice › Side effects · 10 Jul 2026 · 10 likes Adding the measurement that post #14 says would settle it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #47 · Nutrition & Training › Protein & intake · 9 Jul 2026 · 6 likes What tends to work is front-loading the day, prioritising density over volume, and treating it as a solvable problem rather than an inconvenience.
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #8 · Clinical › Comorbidities · 9 Jul 2026 · 27 likes Answering the question post #4 raises rather than the one it answers. Post-authorisation safety studies are the place where under-studied populations eventually appear,…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #49 · Outcomes › Body composition · 8 Jul 2026 · 0 likes Everything in post #45 holds. The case it does not cover is the one I have. My position on ultrasound and skinfolds is current rather than settled. I have revised it…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #28 · Start Here › Welcome · 28 Jun 2026 · 8 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Follow-up: Sleep quality changes during weight loss Replied, post #52 · Wellbeing › Sleep · 23 Jun 2026 · 9 likes Where sleep worsened at the same time as an escalation and improved afterwards, that sequence is worth recording rather than reasoning about.
-
Journal club: STEP 3 and the intensive behavioural therapy floor Replied, post #10 · Evidence › Journal club · 9 Jun 2026 · 21 likes I had written a reply contradicting post #6 and deleted it. Here is what survived. On STEP 3, the part that usually goes wrong is that the question is asked as though…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #79 · Sourcing › Vendor reports · 6 Jun 2026 · 9 likes The format we ask for is compound, lot, testing service, method as reported, result, and the certificate figure for the same lot. A report missing any of those goes to…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #10 · Sourcing › Red flags · 2 Jun 2026 · 1 like Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #29 · Analytics › Impurities & related substances · 27 May 2026 · 33 likes On Endotoxin, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #44 · Wellbeing › Sleep · 27 May 2026 · 19 likes A referral for a proper sleep study answers in one night what months of forum discussion cannot. One of those cases where knowing the mechanism does not help the…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #110 · Practice › Interactions · 22 May 2026 · 6 likes Marking my uncertainty on Metformin co-administration explicitly. I am confident about the direction, much less confident about the size, and not confident at all that…
-
Preservatives: function, testing, and limits — one year on Replied, post #18 · Pharmacology › Formulation chemistry · 21 May 2026 · 3 likes Aggregation is concentration-dependent, which is why reconstituting to a high concentration is not always the convenient choice it appears to be. The short version is…
-
What a certificate commits its issuer to — one year on Replied, post #64 · Analytics › COA interpretation · 8 May 2026 · 1 like Post #60 and I disagree about the size of the effect, not about the direction. A certificate of analysis is a statement by its issuer that a defined test was performed…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #39 · Practice › Reconstitution · 5 May 2026 · 25 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #105 · Compounds › Tirzepatide · 1 May 2026 · 4 likes Building on post #104 rather than restating it. What I want from this 2.5 mg starting dose thread is the list of things that would need to be true for the claim to…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #20 · Clinical › Comorbidities · 24 Apr 2026 · 1 like A note on how PCOS and metabolic overlap gets discussed rather than on PCOS and metabolic overlap itself: the confident posts get the replies and the careful ones get…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #40 · Clinical › Bloodwork · 15 Apr 2026 · 6 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial.
-
Primary endpoint hierarchies and why order matters Replied, post #4 · Evidence › Trials · 12 Apr 2026 · 0 likes Taking the opening post at face value and following it one step further. Pre-specification is the property that makes a primary endpoint trustworthy. An endpoint chosen…
-
Follow-up: State-level differences that actually matter Replied, post #74 · Regional › North America · 8 Apr 2026 · 0 likes I read post #72 twice before replying, because I had assumed the opposite. Source for the State-level differences figure, since it was asked for. It is in the…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #54 · Outcomes › Body composition · 6 Apr 2026 · 15 likes Narrowing post #51, because the general version has more than one answer. Percentage body fat is a ratio, so it changes when either component changes. A rising…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #86 · Practice › Reconstitution · 4 Apr 2026 · 2 likes I would be cautious about generalising from the Foaming during reconstitution example above. It is a good example. It is one example.
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #12 · Lounge › Introductions · 3 Apr 2026 · 22 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community. The step people skip is the…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #63 · Compounds › Tirzepatide · 30 Mar 2026 · 16 likes No notes. Posting so the count is not one.
-
Designing a personal experiment that could change your mind — one year on Replied, post #26 · Research Methods › N-of-1 designs · 28 Mar 2026 · 21 likes Adding a reference point for Designing a personal experiment. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #15 · Practice › Interactions · 24 Mar 2026 · 0 likes Two sentences on widely repeated interaction claim and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #45 · Access › International · 22 Mar 2026 · 21 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #76 · Pharmacology › Pharmacokinetics · 19 Mar 2026 · 7 likes Taking post #75 at face value and following it one step further. Two sentences on Washout and then I will stop, because the rest is speculation and the thread is better…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #10 · Sourcing › Vendor reports · 19 Mar 2026 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Report the certificate figure alongside the independent one. The comparison is the…
-
What a certificate commits its issuer to — one year on Replied, post #33 · Analytics › COA interpretation · 17 Mar 2026 · 26 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #68 · Research Methods › N-of-1 designs · 15 Mar 2026 · 0 likes I disagree with the framing of ABAB design above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #70 · Analytics › Mass spectrometry · 15 Mar 2026 · 0 likes Adducts is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Requesting a translation of an existing page — the long version Started this topic · Documentation › Wiki requests · 12 Mar 2026 · 57 likes Posting this under the heading it deserves: Requesting a translation of an existing page — the long version Everything below is what sits behind that. Requesting a…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #14 · Sourcing › Logistics · 10 Mar 2026 · 4 likes An observation about Regional warehouse stock versus direct that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #36 · Practice › Reconstitution · 9 Mar 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Request: export my own posts — one year on Replied, post #56 · Meta › Feature requests · 8 Mar 2026 · 4 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #92 · Meta › Site feedback · 7 Mar 2026 · 9 likes Two claims get bundled together under topic list and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #94 · Clinical › Bloodwork · 7 Mar 2026 · 33 likes Taking post #91 at face value and following it one step further. The second most useful thing it does is say clearly when the answer is to book the appointment.
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #38 · Analytics › Impurities & related substances · 25 Feb 2026 · 21 likes Taking post #35 at face value and following it one step further. Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they elute…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #58 · Practice › Dosing & titration · 18 Feb 2026 · 3 likes Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful record anyone here keeps. Memory reconstructs a titration…
-
Preprint servers and what screening they do Replied, post #56 · Evidence › Preprints · 14 Feb 2026 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. The short answer was…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #54 · Analytics › Mass spectrometry · 13 Feb 2026 · 25 likes Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a million. On a high-resolution instrument a low single-digit figure is…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #65 · Documentation › Wiki requests · 1 Feb 2026 · 21 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change. Speaking for myself and not for…
-
Run-in periods and the population they select Replied, post #59 · Evidence › Trials · 1 Feb 2026 · 29 likes Worth separating two things that post #55 runs together. The strongest argument against my own position on run-in periods, stated as well as I can state it, since…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #18 · Outcomes › Body composition · 25 Jan 2026 · 0 likes Post #15 is right about the mechanism and I think understates the practical bit. DXA (dual-energy X-ray absorptiometry): the standard for body composition in research.…
-
Coverage in the US: a map of the usual obstacles Replied, post #41 · Regional › North America · 25 Jan 2026 · 27 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #63 · Pharmacology › Pharmacokinetics · 19 Jan 2026 · 3 likes The thing about Half-life that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
A partial dose because the pen emptied mid-injection Replied, post #74 · Practice › Administration · 9 Jan 2026 · 21 likes Post #70 and I disagree about the size of the effect, not about the direction. Practical experience of partial dose because the pen, offered as one case with the…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #21 · Documentation › Wiki requests · 2 Jan 2026 · 0 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #38 · Pharmacology › Receptor biology · 2 Jan 2026 · 0 likes Receptor occupancy required for a clinical effect is not the same as full occupancy, and dose-response curves flattening at the top is what you would expect from that.…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #123 · Practice › Reconstitution · 19 Dec 2025 · 0 likes Where I part company with post #121, and it is a narrow parting. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #11 · Compounds › Semaglutide · 7 Dec 2025 · 2 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #25 · Compounds › Tirzepatide · 3 Dec 2025 · 8 likes Adding the measurement that post #24 says would settle it. Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak.…
-
Personal import allowances, compared — a second dataset Replied, post #28 · Access › International · 28 Nov 2025 · 7 likes Taking post #27 at face value and following it one step further. Import rules for personal use: what you can import for personal use depends on your country's rules,…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #21 · Devices › Pens & autoinjectors · 25 Nov 2025 · 4 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #5 · Research Methods › N-of-1 designs · 23 Nov 2025 · 1 like Post #4 is right about the mechanism and I think understates the practical bit. Objective versus subjective measures: subjective measures (how you feel) are vulnerable…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #43 · Analytics › Impurities & related substances · 23 Nov 2025 · 15 likes Fair, and the limits you put on it are the part I will remember.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #3 · Practice › Reconstitution · 22 Nov 2025 · 13 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Prescription requirements and telehealth models Replied, post #24 · Sourcing › Regulatory · 21 Nov 2025 · 10 likes Picking up post #21: that is the part I would want checked first. Prescription requirements and telehealth models has a well-known answer and a correct answer, and the…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #122 · Start Here › How to Ask · 21 Nov 2025 · 0 likes Everything in post #119 holds. The case it does not cover is the one I have. Context that matters: compound, how long in, current dose, relevant history. Context that…
-
Batch date after test date, and other internal inconsistencies Replied, post #18 · Analytics › COA interpretation · 17 Nov 2025 · 18 likes Everything in post #14 holds. The case it does not cover is the one I have. Batch date is a good example of a question where the honest answer is boring and the…
-
EMA product information as a primary source Replied, post #70 · Regional › European Union · 15 Nov 2025 · 11 likes Adding a reference point for EMA product information. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
Documentation that appears only after payment Replied, post #70 · Sourcing › Red flags · 7 Nov 2025 · 0 likes The arithmetic in post #69 is right; the assumption feeding it is the part to check. What I would want before treating documentation as settled: the method, the sample,…
-
Sleep quality changes during weight loss — what changed since Replied, post #53 · Wellbeing › Sleep · 6 Nov 2025 · 26 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #8 · Compounds › Tirzepatide · 6 Nov 2025 · 2 likes Adding a reference point for tirzepatide titration schedules. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
Temperature loggers worth the money — the long version Replied, post #69 · Devices › Cold chain · 5 Nov 2025 · 0 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #30 · Sourcing › Vendor reports · 31 Oct 2025 · 2 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #83 · Documentation › Doc review · 29 Oct 2025 · 0 likes The arithmetic in post #82 is right; the assumption feeding it is the part to check. Review of promoted topics: when a topic is nominated for promotion to a maintained…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #98 · Practice › Storage & stability · 22 Oct 2025 · 4 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Caveat: everything above assumes the…
-
New subcategory: rationale and scope Replied, post #61 · Meta › Announcements · 19 Oct 2025 · 32 likes Picking up post #60: that is the part I would want checked first. The practical version of new subcategory is three sentences long. The rigorous version is three pages…
-
New subcategory: rationale and scope Replied, post #25 · Meta › Announcements · 14 Oct 2025 · 26 likes Practical experience of new subcategory, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Reading SURMOUNT-1 without the press release Replied, post #26 · Compounds › Tirzepatide · 6 Oct 2025 · 13 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #112 · Practice › Side effects · 2 Oct 2025 · 31 likes Building on post #111 rather than restating it. What I would check first on nausea timeline is whether the thing being measured moved or whether the way of measuring it…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #20 · Evidence › Preprints · 27 Sep 2025 · 1 like Answering the question post #18 raises rather than the one it answers. For anyone finding this later: the short answer on Citing a preprint is that it depends on one…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #48 · Compounds › Repair & healing peptides · 26 Sep 2025 · 1 like This follows post #45 rather than contradicting it. Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #80 · Practice › Side effects · 21 Sep 2025 · 0 likes On post #76 — agreed on the reasoning, with one qualification. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
-
Discussing something you have already been doing Replied, post #7 · Clinical › Prescriber conversations · 20 Sep 2025 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
Hypertension improvement and when medication needs revisiting Replied, post #37 · Clinical › Comorbidities · 2 Sep 2025 · 0 likes The practical version of hypertension improvement is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
How to read a forest plot, properly, from scratch Replied, post #19 · Evidence › Trials · 24 Aug 2025 · 13 likes The arithmetic in post #16 is right; the assumption feeding it is the part to check. Absolute and relative effects answer different questions. Write down the event rate…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #4 · Analytics › Impurities & related substances · 24 Aug 2025 · 8 likes The opening post answers the question as asked. The question underneath it is different. Aggregates may be a multiple of the monomer mass and may not elute at all under…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #40 · Evidence › Preprints · 23 Aug 2025 · 11 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Journal club: how we handle discontinuation in obesity trials Replied, post #2 · marked as the solution · Evidence › Journal club · 19 Jul 2025 · 19 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and…
-
Sodium, potassium and magnesium when intake drops Replied, post #58 · Nutrition & Training › Hydration & electrolytes · 14 Jul 2025 · 5 likes Very low total intake produces multiple simultaneous deficiencies rather than one, which is why single-nutrient reasoning goes wrong here. Reporting the observation and…
-
Preparing for an appointment: one page, three questions Replied, post #26 · Clinical › Prescriber conversations · 7 Jul 2025 · 19 likes Noted, and thank you for writing it out rather than summarising it.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #61 · Clinical › Comorbidities · 29 Jun 2025 · 18 likes Adding the measurement that post #58 says would settle it. Post-authorisation safety studies are the place where under-studied populations eventually appear, and they…
-
Coming back to: When "no data" is the complete and final answer Replied, post #25 · Compounds › Other compounds · 26 Jun 2025 · 5 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Sequence verification for an obscure compound: how it is done Replied, post #66 · Compounds › Other compounds · 18 Jun 2025 · 8 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Counter-ion content and its effect on measured mass Replied, post #65 · Analytics › Mass spectrometry · 15 Jun 2025 · 4 likes Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a million. On a high-resolution instrument a low single-digit figure is…
-
Which panel is worth repeating and which is worth ignoring Replied, post #38 · Clinical › Bloodwork · 14 Jun 2025 · 11 likes Post #36 describes the usual case. This is about the unusual one. Small correction to my own earlier position on panel. I had the units the wrong way round, which…
-
Sequence verification for an obscure compound: how it is done Replied, post #57 · Compounds › Other compounds · 8 Jun 2025 · 0 likes On sequence verification: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #31 · Access › Insurance & coverage · 8 Jun 2025 · 18 likes The reason appeal keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #98 · Sourcing › Red flags · 20 May 2025 · 27 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #100 · Devices › Cold chain · 9 May 2025 · 9 likes I had written a reply contradicting post #98 and deleted it. Here is what survived. Regional stock shortens the exposure window more effectively than any packing…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #17 · Evidence › Trials · 25 Apr 2025 · 10 likes Post #16 answers the question as asked. The question underneath it is different. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but…
-
Metformin co-administration and additive GI effects Replied, post #4 · Practice › Interactions · 19 Apr 2025 · 10 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #98 · Evidence › Journal club · 16 Apr 2025 · 2 likes On post #96 — agreed on the reasoning, with one qualification. People arriving without having read it should be welcome and should say so, because a question from…
-
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class Replied, post #2 · Clinical › Comorbidities · 12 Apr 2025 · 0 likes A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history.
-
Coverage for the indication versus for the drug Replied, post #18 · Access › Insurance & coverage · 3 Apr 2025 · 17 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
-
Retatrutide dose escalation in the published trials Replied, post #80 · Compounds › Retatrutide · 2 Apr 2025 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #64 · Practice › Reconstitution · 27 Mar 2025 · 0 likes Coming back to post #62, because the follow-up matters more than the original answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #73 · Documentation › Doc review · 24 Mar 2025 · 10 likes Building on post #72 rather than restating it. Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #128 · Pharmacology › Receptor biology · 19 Mar 2025 · 0 likes The version of biased agonism that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #95 · Sourcing › Vendor reports · 17 Mar 2025 · 12 likes Narrowing post #92, because the general version has more than one answer. Comparing your result to somebody else's on a different lot is not a comparison of suppliers.…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #74 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Where you have no independent result, a documentation report is still worth filing: what the certificate contained, what it omitted, and how fast a request was…
-
Validating a method you did not develop — does this still hold? Replied, post #116 · Analytics › Method validation · 15 Mar 2025 · 0 likes Narrowing post #115, because the general version has more than one answer. I would keep Validating a method and the decision it usually gets used for separate in this…
-
Reading order for a first week here, and what to skip until later Replied, post #34 · Start Here › Welcome · 12 Mar 2025 · 2 likes Since reading order keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Follow-up: Is "synergy" the right word for the combination data? Started this topic · Compounds › Cagrilintide & amylin analogues · 6 Mar 2025 · 0 likes Is "synergy" the right word for the combination data? I have a specific reason for asking rather than idle curiosity, and the context is below. Putting the numbers in…
-
Adjudicated events and why the definition matters — the long version Replied, post #30 · Evidence › Trials · 2 Mar 2025 · 22 likes Trying to state the Adjudicated events position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
-
Scheduled maintenance and what will be unavailable Replied, post #55 · Meta › Announcements · 26 Feb 2025 · 17 likes Adding the measurement that post #54 says would settle it. The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #124 · Evidence › Journal club · 11 Feb 2025 · 12 likes What I would check first on SURPASS-2 is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #38 · Access › International · 11 Feb 2025 · 3 likes Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.
-
Distinguishing a deletion sequence by mass alone Replied, post #40 · Analytics › Mass spectrometry · 1 Feb 2025 · 33 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Triple agonism: additive, synergistic, or neither? Replied, post #14 · Compounds › Retatrutide · 29 Jan 2025 · 28 likes That reframing is the whole thing. The facts I already had.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #19 · Analytics › COA interpretation · 18 Jan 2025 · 16 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
[2026 update] New subcategory: rationale and scope Replied, post #98 · Meta › Announcements · 27 Dec 2024 · 4 likes Post #94 describes the usual case. This is about the unusual one. Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #55 · Compounds › Semaglutide · 22 Dec 2024 · 11 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Body image changing more slowly than the body Replied, post #81 · Wellbeing › Mental health · 20 Dec 2024 · 0 likes Answering the body image question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
[2026 update] New subcategory: rationale and scope Replied, post #44 · Meta › Announcements · 5 Dec 2024 · 0 likes Post #41 is right about the mechanism and I think understates the practical bit. The edit is clearer. For anyone arriving now, read the edited version — the confusion…
-
Washout with a one-week half-life: the arithmetic Replied, post #70 · Research Methods › N-of-1 designs · 5 Dec 2024 · 0 likes Washout looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
When to suspect the method rather than the sample Replied, post #37 · Analytics › Method validation · 15 Nov 2024 · 11 likes A stability-indicating method is one demonstrated to resolve the analyte from its degradation products, usually through forced degradation. Calling a method…
-
What a seizure notice actually says Replied, post #8 · Sourcing › Logistics · 13 Nov 2024 · 8 likes I have three months of notes on seizure notice and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #23 · Access › Insurance & coverage · 11 Nov 2024 · 22 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #49 · Compounds › Other compounds · 14 Oct 2024 · 2 likes Following this. I have the same question and no better information than the first post.
-
Tracking a preprint to publication: a worked example — the long version Replied, post #47 · Evidence › Preprints · 9 Oct 2024 · 3 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #70 · Clinical › Prescriber conversations · 4 Oct 2024 · 4 likes Answering the question post #68 raises rather than the one it answers. Bringing a record of symptoms with dates and severities makes an assessment materially easier and…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #48 · Sourcing › Independent verification · 10 Sep 2024 · 12 likes Worth separating two things that post #46 runs together. Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #5 · Practice › Interactions · 1 Sep 2024 · 30 likes Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #4 · Compounds › Tirzepatide · 21 Aug 2024 · 7 likes Adding the measurement that post #3 says would settle it. The published pharmacokinetics show dose proportionality across the studied range, which means dose arithmetic…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #9 · Analytics › Mass spectrometry · 11 Aug 2024 · 3 likes Post #5 and I disagree about the size of the effect, not about the direction. Where I would push back on the High-resolution consensus is the confidence, not the…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #31 · Practice › Dosing & titration · 26 Jun 2024 · 21 likes An honest declaration on four-week escalation interval: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…